P. Li et al. / Tetrahedron 64 (2008) 7633–7638
7637
13C NMR (75 MHz, CDCl
3.6, 42.6, 33.2,28.5, 25.0, 21.0. syn/anti¼99:1;ee¼99%;[
.2, CH
Cl); HPLC (Chiralpak AD-H, i-propanol/hexane¼10:90, flow
rate 1.0 mL/min,
¼254 nm): tminor¼8.48 min, tmajor¼10.68 min.
2.05 (m,1H),1.83–1.56 (m, 4H),1.29–1.15 (m,1H); 13C NMR (75 MHz,
CDCl ): 211.6, 136.3,133.5, 129.6,129.1, 122.9, 78.5, 52.4, 43.4, 42.6,
33.2, 29.5, 28.3, 25.1. syn/anti¼99:1; ee¼99%; [
CH
Cl); HPLC (Chiralpak AD-H, i-propanol/hexane¼10:90, flow rate
.0 mL/min,
¼254 nm): tminor¼15.29 min, tmajor¼18.60 min.
3
): d 212.0,137.4,134.6,129.7,128.0, 79.0, 52.6,
25
4
1
a]
D
ꢁ26.3(c
3
d
2
5
3
a
]
D
ꢁ29.8 (c 1.0,
l
3
1
l
4
.3.3. (S)-2-((R)-1-(4-Methoxyphenyl)-2-nitroethyl)cyclo-
7a
hexanone 7c
4.3.9. (S)-2-((R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-nitroethyl)-
1H NMR (300 MHz, CDCl
11f
3
):
d
7.08 (d, J¼8.7 Hz, 2H), 6.84 (d,
cyclohexanone 7i
1
J¼8.7 Hz, 2H), 4.93 (dd, J¼4.5, 12.3 Hz, 1H), 4.58 (dd, J¼9.9, 12.0 Hz,
H NMR (300 MHz, CDCl
3
):
d
6.75 (d, J¼7.8 Hz, 1H), 6.66 (s, 2H),
1
2
(
H), 3.78 (s, 3H), 3.72 (dt, J¼4.5, 9.9 Hz, 1H), 2.68–2.60 (m, 1H),
6.64–6.58 (m, 2H), 5.96 (s, 2H), 4.92 (dd, J¼4.5, 12.3 Hz, 1H), 4.56
(dd, J¼4.5, 9.9 Hz, 1H), 3.67 (dt, J¼4.5, 9.9 Hz, 1H), 2.68–2.56 (m,
1H), 2.51–2.33 (m, 2H), 2.15–2.07 (m, 1H), 1.83–1.61 (m, 4H), 1.31–
.52–2.32 (m, 2H), 2.12–2.03 (m, 1H), 1.82–1.51 (m, 4H), 1.30–1.16
m, 1H); 13C NMR (75 MHz, CDCl
):
d 212.1, 137.4, 134.6, 129.6, 128.0,
3
13
7
9.0, 52.6, 43.6, 42.7, 33.2, 28.5, 25.0, 21.0. syn/anti¼99:1; ee¼99%;
3
1.25 (m, 1H); C NMR (75 MHz, CDCl ): d 211.7, 148.0, 147.1, 131.2,
2
5
[
a
]
D
ꢁ19.2 (c 1.2, CH
3
Cl); HPLC (Chiralpak AD-H, i-propanol/
¼254 nm): ¼
121.6, 108.5, 108.0, 101.2, 78.9, 52.5, 43.6, 42.6, 33.2, 28.3, 25.1. syn/
anti¼98:2; ee¼98%; HPLC (Chiralpak AD-H, i-propanol/
hexane¼10:90, flow rate 1.0 mL/min,
l
t
minor
13.22 min, tmajor¼16.41 min.
hexane¼10:90, flow rate 1.0 mL/min,
l¼254 nm): tminor¼17.49 min,
t
major¼18.70 min.
4
.3.4. (S)-2-((R)-1-(4-Bromophenyl)-2-nitroethyl)cyclo-
15a
7b
hexanone 7d
4.3.10. (S)-2-((S)-1-(Furan-2-yl)-2-nitroethyl)cyclohexanone 7j
1H NMR (300 MHz, CDCl
):
d
7.45 (d, J¼8.7 Hz, 2H), 7.06 (d,
1
H NMR (300 MHz, CDCl
):
d
7.36 (d, J¼1.2 Hz, 1H), 6.29 (dd,
3
3
J¼8.4 Hz, 2H), 4.92 (dd, J¼4.5, 12.6 Hz, 1H), 4.60 (dd, J¼9.9, 12.6 Hz,
J¼1.8, 3.3 Hz, 1H), 6.16 (d, J¼3.3 Hz, 1H), 4.81–4.62 (m, 2H), 3.99 (dt,
J¼4.8, 9.3 Hz, 1H), 2.79–2.71 (m, 1H), 2.51–2.32 (m, 2H), 2.16–2.07
1
H), 3.74 (dt, J¼4.5, 9.9 Hz, 1H), 2.69–2.59 (m, 1H), 2.52–2.32 (m,
13
13
2
H), 2.15–2.05 (m, 1H), 1.83–1.54 (m, 4H), 1.30–1.17 (m, 1H);
): 210.9, 148.5, 140.1, 134.8, 129.9, 122.9, 78.0,
2.2, 43.6, 42.7, 33.2, 28.3, 25.0. syn/anti¼99:1; ee¼98%; HPLC
Chiralpak AD-H, i-propanol/hexane¼10:90, flow rate 1.0 mL/min,
¼254 nm): tminor¼11.92 min, tmajor¼18.65 min.
C
(m, 1H), 1.92–1.56 (m, 4H), 1.35–1.23 (m, 1H); C NMR (75 MHz,
NMR (75 MHz, CDCl
5
(
l
3
d
CDCl
28.2, 25.0. syn/anti¼99:1; ee>99%; [
(Chiralpak AD-H, i-propanol/hexane¼10:90, flow rate 1.0 mL/min,
¼254 nm): tmajor¼10.53 min, tminor¼12.86 min.
3
): d 210.9, 150.8, 142.3, 110.3, 108.9, 76.6, 51.0, 42.5, 37.5, 32.4,
2
5
a]
D
ꢁ15.2 (c 1.5, CH
3
Cl); HPLC
l
4
.3.5. (S)-2-((R)-1-(3-Bromophenyl)-2-nitroethyl)cyclo-
4.3.11. (S)-2-((R)-2-(Naphthalen-1-yl)-2-nitroethyl)cyclo-
hexanone 7k
11g
7d
hexanone 7e
1HNMR(300 MHz,CDCl
d
7.40(d, J¼7.8 Hz,1H), 7.33(s,1H), 7.21
1H NMR (300 MHz, CDCl
):
d
7.84–7.79 (m, 3H), 7.63 (d, J¼1.2 Hz,
3
):
3
(
t, J¼7.8 Hz, 1H), 7.10 (d, J¼7.5 Hz, 1H), 4.93 (dd, J¼4.5, 12.9 Hz, 1H),
1H), 7.49–7.46 (m, 2H), 7.30–7.26 (m, 1H), 5.02 (dd, J¼4.5, 12.6 Hz,
1H), 4.73 (dd, J¼9.9, 12.3 Hz, 1H), 3.99–3.92 (m, 1H), 2.78–2.75 (m,
4
2
1
.62 (dd, J¼9.9, 12.6 Hz, 1H), 3.77–3.68 (m, 1H), 2.65–2.62 (m, 1H),
.50–2.38 (m, 2H), 2.11–2.05 (m,1H),1.79–1.57 (m, 4H),1.30–1.20 (m,
1H), 2.50–2.47 (m, 2H), 2.42–2.39 (m, 1H), 1.76–1.58 (m, 4H), 1.29–
13
13
H); C NMR (75 MHz, CDCl
22.8, 78.3, 52.2, 43.6, 42.7, 33.1, 28.4, 25.0. syn/anti¼98:2;
ee¼96%; HPLC (Chiralpak AD-H, i-propanol/hexane¼10:90, flow rate
.0 mL/min,
¼254 nm): tminor¼10.86 min, tmajor¼12.21 min.
3
):
d
211.2,140.1,131.2,130.9,130.4,126.9,
1.25 (m, 1H); C NMR (75 MHz, CDCl
3
):
d
211.8, 135.1, 133.4, 132.8,
1
128.9, 127.9, 127.7, 126.5, 126.2, 125.2, 78.8, 76.6, 52.5, 44.1, 42.8,
2
5
33.3, 28.5, 25.0. syn/anti>99:1; ee>99%; [
HPLC (Chiralpak AD-H, i-propanol/hexane¼30:70, flow rate 1.0 mL/
min,
¼254 nm): tminor¼8.83 min, tmajor¼14.45 min.
a
]
D
ꢁ69.2 (c 1.1, CH
3
Cl);
1
l
l
4.3.6. (S)-2-((R)-1-(2-Bromophenyl)-2-nitroethyl)cyclo-
11f
hexanone 7f
4.3.12. (S)-2-((R)-1-(Naphthalen-1-yl)-2-nitroethyl)cyclo-
1H NMR (300 MHz, CDCl
11f
3
):
d
7.57 (d, J¼8.1 Hz, 1H), 7.32–7.21 (m,
hexanone 7l
2
1
H), 7.15–7.10 (m, 1H), 4.90 (d, J¼8.1 Hz, 2H), 4.32 (dd, J¼6.3, 6.6 Hz,
1H NMR (300 MHz, CDCl
3
):
d
8.17 (s, 1H), 7.86 (d, J¼7.8 Hz, 1H),
H), 2.91–2.88 (m, 1H), 2.45–2.34 (m, 2H), 2.12–2.08 (m, 1H), 1.84–
7.75 (d, J¼8.1 Hz,1H), 7.60–7.35 (m, 4H), 5.06 (dd, J¼4.5,12.6 Hz,1H),
13
1
1
.53 (m, 4H), 1.40–1.20 (m, 1H); C NMR (75 MHz, CDCl
37.2, 133.6, 129.0, 127.9, 77.3, 52.1, 43.0, 42.6, 41.9, 32.9, 28.5, 25.2.
syn/anti¼99:1; ee¼98%; HPLC (Chiralpak AD-H, i-propanol/
3
):
d
211.6,
4.91–4.88 (m, 1H), 4.76 (s, 1H), 2.65 (br s, 1H), 2.45–2.38 (m, 2H),
13
2.09–2.04 (m, 1H), 1.69–1.47 (m, 4H), 1.29–1.20 (m, 1H); C NMR
(75 MHz, CDCl ): 212.1,134.5,128.9,128.1,126.3,125.7,125.1,123.5,
3
d
hexane¼10:90, flow rate 1.0 mL/min,
l¼254 nm):
t
minor
¼
122.4, 78.6, 53.5, 42.7, 36.5, 33.1, 28.5, 25.1. syn/anti¼98:2; ee¼
98%; HPLC (Chiralpak AS-H, i-propanol/hexane¼30:70, flow rate
10.00 min, tmajor¼15.90 min.
1.0 mL/min,
l¼254 nm): tminor¼10.60 min, tmajor¼15.61 min.
4
.3.7. (S)-2-((R)-1-(4-Fluorophenyl)-2-nitroethyl)cyclo-
11g
hexanone 7g
4.3.13. (R)-Tetrahydro-3-((R)-2-nitro-1-phenylethyl)pyran-
1
14b
H
NMR (300 Hz, CDCl
3
):
d
7.16 (d, J¼8.1 Hz, 2H), 7.02
4-one 7m
(
1
d, J¼8.4 Hz, 2H), 4.94 (dd, J¼4.5, 12.6 Hz, 1H), 4.59 (dd, J¼10.2,
1H NMR (300 MHz, CDCl
3
): d 7.39–7.27 (m, 3H), 7.24–7.17 (m,
2.6 Hz, 1H), 3.81–3.73 (m, 1H), 2.69–2.61 (m, 1H), 2.50–2.32 (m,
2H), 4.78–4.62 (m, 2H), 4.11–4.02 (m, 1H), 3.87–3.75 (m, 2H), 3.70
13
2
H), 2.12–2.05 (m, 1H), 1.88–1.51 (m, 4H), 1.30–1.15 (m, 1H);
): 211.7, 133.4, 129.7, 129.5, 124.6, 124.4,
16.0, 115.7, 78.8, 52.4, 43.2, 42.7, 33.2, 28.4, 25.0. syn/anti¼98:2;
ee¼97%; HPLC (Chiralpak AD-H, i-propanol/hexane¼10:90, flow
rate 1.0 mL/min,
¼254 nm): tminor¼11.69 min, tmajor¼15.79 min.
C
(dd, J¼4.8, 11.7 Hz, 1H), 3.29 (dd, J¼9.6, 11.4 Hz, 1H), 2.93–2.85 (m,
13
NMR (75 MHz, CDCl
3
d
1H), 2.73–2.62 (m, 1H), 2.58–2.49 (m, 1H); C NMR (75 MHz,
1
CDCl
31.7. syn/anti¼95:5; ee¼95%; HPLC (Chiralpak AS-H, i-propanol/
hexane¼30:70, flow rate 1.0 mL/min, ¼254 nm): tminor¼11.63 min,
major¼16.93 min.
3
): d 209.3, 136.3, 129.2, 128.3, 128.0, 78.6, 54.7, 44.6, 43.5, 35.2,
l
l
t
4.3.8. (S)-2-((R)-1-(4-Chlorophenyl)-2-nitroethyl)cyclo-
11g
hexanone 7h
4.3.14. (R)-Tetrahydro-3-((R)-2-nitro-1-phenylethyl)thiopyran-4-
1H NMR (300 MHz, CDCl
14b
3
):
d
7.31 (d, J¼8.4 Hz, 2H), 7.16 (d,
one 7n
J¼8.4 Hz, 2H), 4.93 (dd, J¼4.5, 12.6 Hz, 1H), 4.60 (dd, J¼9.9, 12.6 Hz,
H), 3.78–3.70 (m, 1H), 2.68–2.60 (m, 1H), 2.50–2.32 (m, 2H), 2.12–
1H NMR (300 MHz, CDCl
3
):
d 7.38–7.28 (m, 3H), 7.23–7.17 (m,
1
2H), 4.75 (dd, J¼4.8, 12.6 Hz, 1H), 4.65 (dd, J¼9.6, 12.3 Hz, 1H), 4.01